SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Better-than-expected quarterly results, raised guidance, and a growing backlog signaling strong AI-compute demand drove attention and a sharp after-hours rally. Many traders celebrated the outlook and anticipated short covering, while others questioned whether heavy debt, interest costs, and capital spending will translate into sustainable profits.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results and conference call are the main focus, with traders weighing improved profitability and Samsung licensing revenue against an apparent miss versus some analyst estimates; much of the debate centers on the upfront Samsung payment being recognized over the license term. Many are optimistic about recurring licensing income from Micron and stronger margins, while a possible SK Hynix deal or Nasdaq uplisting remains speculation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is drawing attention after selling off despite encouraging CTX310 clinical data on lipid reduction and FDA RMAT designations. Bulls see the results and growing CASGEVY rollout as evidence of pipeline and commercial progress, while skeptics argue early-stage data has not changed the outlook enough to overcome concerns about execution and the stocks muted response to positive news.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths stronger-than-expected Q3 results, improved medical-cost ratio and raised outlook have renewed debate over whether its turnaround is taking hold. Bulls also cite the expanded buyback and demand for defensive healthcare stocks, while skeptics point to choppy trading and lingering Medicare Advantage and regulatory concerns.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,011,579 in circulation. The last known price of Autonomi is 0.03102024 USD and is up 12.83 over the last 24 hours. It is currently trading on 15 active market(s) with $148,822.58 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Discussion is fragmented, with much of the chatter confusing Aragons ANT token with Anthropics unrelated IPO ticker. Aragon-focused posts mention its dissolved project and completed token-redemption initiative, alongside speculative reactions to the tokens price move; theres no clear new catalyst established.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Waves Q3 results have fueled a sharp selloff, as traders weigh revenue growth and a large backlog against soft bookings, high costs, and the companys distance from profitability. Bulls point to cash, customer activity, and quantum-computing potential, while bears argue the valuation remains excessive and commercial demand has yet to translate into meaningful revenue.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors Q3 call reaffirming confidence in deramiocel and saying its application is in final FDA review has focused attention on the November 22 decision for Duchenne muscular dystrophy. Many traders read managements comments and launch preparations as encouraging, while others stress that approval remains uncertain given the FDA advisory panels concerns; interpretations of possible label discussions are speculation.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

Shares are under pressure after Ons Q3 report, with traders focused on unchanged full-year sales-growth guidance and a headline beat partly boosted by tariff refunds; some also point to softer direct-to-consumer sales. The reaction is split between dip-buyers and investors disappointed that strong reported results did not bring a stronger outlook.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,103,675.095707 in circulation. The last known price of Algorand is 0.08996747 USD and is down -2.64 over the last 24 hours. It is currently trading on 586 active market(s) with $54,766,948.47 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorand is drawing attention amid continued price weakness and bearish technical signals, with traders debating whether the decline will deepen or has created an accumulation opportunity. Bulls cite tokenization and the networks technology as long-term potential, while skeptics point to ALGOs prolonged underperformance and see rallies as temporary.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles upcoming Q3 report is the main focus, with traders weighing whether Northern Data and Quake AI revenueand progress monetizing the Anthropic compute agreementcan support growth. Bulls point to elevated short interest as potential fuel for a squeeze, while skeptics question financing, dilution and execution and warn that strong revenue alone may not lift shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alcoa Corp: UBS downgrades stock, says alumina ’down and out’

Investing.com -- UBS cut its rating for  Alcoa  (NYSE:AA) Corp. to Neutral from Buy on Thursday, warning that the outlook for alumina remains weak and the company’s valuation is no longer compelling following a recent stock rebound.

BofA downgrades Alcoa on weaker Aluminum, Alumina outlook

Investing.com -- Bank of America downgraded  Alcoa  (NYSE:AA) Corp to Underperform from Buy given a weaker outlook for aluminum and alumina prices and growing uncertainty around demand, especially into 2025 and 2026.

Alcoa shares up after Q4 beat, forecasts stable alumina production for 2025

Investing.com --  Alcoa  Corp (NYSE:AA) posted fourth-quarter adjusted earnings of $1.04 per share, beating analysts' expectations by 11 cents, while revenue climbed to $3.49 billion, beating consensus estimates of $3.29 billion. Shares of the company were up more than 3% in aftermarket trading.

Neutral Sentiment

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Feed

News

Sentiment

Fundamentals

Info

AAI AirTran Holdings Inc.

Latest AAI News